Merck & Co Inc MRK

Healthcare

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand.

NYSE:MRK - Post by User

Merck & Co Inc

Bullboard Posts

Post by Threeclickson Nov 23, 1999 7:30am

219 Views

Post# 1093406

New drug can be taken weekly

Liz Claman, Business News, talked about MRK this morning on CNBC. MRK osteoporosis bone drug may soon be taken weekly. $1B in sales is seen for this drug. Claman also talked about AHP. For analysts views on MRK https://www.netcognizance.com/Pharma.htm#Views_on_MRK AHP https://www.netcognizance.com/Pharma.htm#Views_on_AHP

Bullboard Posts

Hudbay signs US$300M financing to advance B.C. copper project